[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555646":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":256,"collaborators":19,"id":258,"slug":19,"hasResults":259,"nctId":260,"briefTitle":261,"officialTitle":262,"acronym":19,"eligibilityCriteria":263,"healthyVolunteers":259,"sex":264,"minAge":265,"maxAge":19,"enrollmentInfo":266,"targetDuration":19,"studyType":269,"phases":270,"briefSummary":272,"conditions":273,"keywords":276,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":278,"lastUpdatePostDateStruct":279,"startDateStruct":282,"completionDateStruct":284,"leadSponsor":286,"locationsCount":287},{"fullName":5,"class":6},"Wugen, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"WU-CART-007","EXPERIMENTAL","A CD7-directed chimeric antigen receptor (CAR) T-cell product.\n\nLymphodepletion",[13],"Biological: WU-CART-007",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BIOLOGICAL","A single IV infusion of WU-CART-007",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Cherry Thomas, MD","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Wugen Clinical Trials","CONTACT","314-501-1968","clinicaltrials@wugen.com",[31,50,70,83,99,113,131,141,155,170,183,199,216,229,247],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"City of Hope","RECRUITING","Duarte","California","91010","United States",{"type":39,"coordinates":40},"Point",[41,42],-117.97729,34.13945,{"lat":42,"lon":41},[45,47],{"name":19,"role":27,"phone":19,"phoneExt":19,"email":46},"tolaitan@coh.org",{"name":48,"role":49,"phone":19,"phoneExt":19,"email":19},"Ibrahim Aldoss, MD","PRINCIPAL_INVESTIGATOR",{"facility":51,"status":33,"city":52,"state":35,"zip":53,"country":37,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Children's Hospital Los Angeles","Los Angeles","90027",{"type":39,"coordinates":55},[56,57],-118.24368,34.05223,{"lat":57,"lon":56},[60,64,68],{"name":61,"role":27,"phone":62,"phoneExt":19,"email":63},"Angela Kang","323-361-2121","akang@chla.usc.edu",{"name":65,"role":27,"phone":66,"phoneExt":19,"email":67},"Amber Medina","(323) 361-5654","ammedina@chla.usc.edu",{"name":69,"role":49,"phone":19,"phoneExt":19,"email":19},"Deepa Bhojwani, MD",{"facility":71,"status":33,"city":72,"state":73,"zip":74,"country":37,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Colorado Blood Cancer Institute","Denver","Colorado","80218",{"type":39,"coordinates":76},[77,78],-104.9847,39.73915,{"lat":78,"lon":77},[81],{"name":82,"role":49,"phone":19,"phoneExt":19,"email":19},"Alireza Eghtedar, M.D.",{"facility":84,"status":33,"city":85,"state":86,"zip":87,"country":37,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"H. Lee Moffitt Cancer Center and Research Institute Hospital","Tampa","Florida","33612",{"type":39,"coordinates":89},[90,91],-82.45843,27.94752,{"lat":91,"lon":90},[94,97],{"name":95,"role":27,"phone":19,"phoneExt":19,"email":96},"Garrett Welch","Garrett.Welch@Moffitt.org",{"name":98,"role":49,"phone":19,"phoneExt":19,"email":19},"Rawan Faramand, M.D.",{"facility":100,"status":33,"city":101,"state":102,"zip":103,"country":37,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Washington University Saint Louis","St Louis","Missouri","63108",{"type":39,"coordinates":105},[106,107],-90.19789,38.62727,{"lat":107,"lon":106},[110],{"name":111,"role":27,"phone":19,"phoneExt":19,"email":112},"Katie Stricker","kstricker@wustl.edu",{"facility":114,"status":33,"city":115,"state":116,"zip":117,"country":37,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"Oncology Hematology Care","Cincinnati","Ohio","45226",{"type":39,"coordinates":119},[120,121],-84.51439,39.12711,{"lat":121,"lon":120},[124,129],{"name":125,"role":27,"phone":126,"phoneExt":127,"email":128},"Doug Hart","513-751-2273","22401","Doug.Hart@USOncology.com",{"name":130,"role":49,"phone":19,"phoneExt":19,"email":19},"Ahmed Galal, MD",{"facility":132,"status":33,"city":115,"state":116,"zip":133,"country":37,"cosmosGeoPoint":134,"geoPoint":136,"contacts":137},"Cincinnati Children's Hospital Medical Center","45229",{"type":39,"coordinates":135},[120,121],{"lat":121,"lon":120},[138],{"name":139,"role":27,"phone":19,"phoneExt":19,"email":140},"Jeremy Rubinstein, MD","Jeremy.Rubinstein@cchmc.org",{"facility":142,"status":33,"city":143,"state":144,"zip":145,"country":37,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Children's Hospital of Philadelphia","Philadelphia","Pennsylvania","19390",{"type":39,"coordinates":147},[148,149],-75.16362,39.95238,{"lat":149,"lon":148},[152],{"name":153,"role":27,"phone":19,"phoneExt":19,"email":154},"Brooke Leibfreid","leibfreidb@chop.edu",{"facility":156,"status":33,"city":157,"state":158,"zip":159,"country":37,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"TriStar Bone Marrow Transplant \u002F Sarah Cannon Transplant & Cellular Therapy","Nashville","Tennessee","37203",{"type":39,"coordinates":161},[162,163],-86.78444,36.16589,{"lat":163,"lon":162},[166,168],{"name":19,"role":27,"phone":19,"phoneExt":19,"email":167},"SCRI.DDUreferrals@scri.com",{"name":169,"role":49,"phone":19,"phoneExt":19,"email":19},"Stephen Strickland, M.D.",{"facility":171,"status":33,"city":172,"state":173,"zip":174,"country":37,"cosmosGeoPoint":175,"geoPoint":179,"contacts":180},"MD Anderson Cancer Center","Houston","Texas","77030",{"type":39,"coordinates":176},[177,178],-95.36327,29.76328,{"lat":178,"lon":177},[181],{"name":182,"role":49,"phone":19,"phoneExt":19,"email":19},"Elias Jabbour, M.D.",{"facility":184,"status":33,"city":185,"state":173,"zip":186,"country":37,"cosmosGeoPoint":187,"geoPoint":191,"contacts":192},"Sarah Cannon Transplant and Cellular Therapy Methodist Hospital","San Antonio","78229",{"type":39,"coordinates":188},[189,190],-98.49363,29.42412,{"lat":190,"lon":189},[193,197],{"name":194,"role":27,"phone":195,"phoneExt":19,"email":196},"Christian Herrera","210-575-6026","SCRI@Methodisttransplantinstitute.com",{"name":198,"role":49,"phone":19,"phoneExt":19,"email":19},"Nosha Farhadfar, M.D.",{"facility":200,"status":33,"city":201,"state":202,"zip":203,"country":37,"cosmosGeoPoint":204,"geoPoint":208,"contacts":209},"Sarah Cannon, Virginia Oncology Associates","Norfolk","Virginia","23502",{"type":39,"coordinates":205},[206,207],-76.28522,36.84681,{"lat":207,"lon":206},[210,214],{"name":211,"role":27,"phone":212,"phoneExt":19,"email":213},"Wendi Gobhardt","757-213-5813","Wendi.Gobhardt@usoncology.com",{"name":215,"role":49,"phone":19,"phoneExt":19,"email":19},"Gary L. Simmons, D.O.",{"facility":217,"status":33,"city":218,"state":219,"zip":220,"country":37,"cosmosGeoPoint":221,"geoPoint":225,"contacts":226},"Seattle Children's Hospital","Seattle","Washington","98105",{"type":39,"coordinates":222},[223,224],-122.33207,47.60621,{"lat":224,"lon":223},[227],{"name":228,"role":49,"phone":19,"phoneExt":19,"email":19},"Adam Lamble, M.D.",{"facility":230,"status":33,"city":231,"state":232,"zip":233,"country":234,"cosmosGeoPoint":235,"geoPoint":239,"contacts":240},"Peter Mac Callum Cancer Institute","Melbourne","Victoria","3000","Australia",{"type":39,"coordinates":236},[237,238],144.96332,-37.814,{"lat":238,"lon":237},[241,244,246],{"name":242,"role":27,"phone":19,"phoneExt":19,"email":243},"Ashish Bajel, M.D.","pcctu.haema@petermac.org",{"name":245,"role":27,"phone":19,"phoneExt":19,"email":19},"PCCTU HaemA",{"name":242,"role":49,"phone":19,"phoneExt":19,"email":19},{"facility":248,"status":33,"city":231,"state":232,"zip":233,"country":234,"cosmosGeoPoint":249,"geoPoint":251,"contacts":252},"Royal Children's Melbourne",{"type":39,"coordinates":250},[237,238],{"lat":238,"lon":237},[253],{"name":254,"role":27,"phone":19,"phoneExt":19,"email":255},"Seong Lin Khaw, M.D.","clinicaltrialsmanager@rch.org.au",{"type":257,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100555646",false,"NCT06514794","A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)","A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in Patients With Relapsed\u002FRefractory Cell Acute Lymphoblastic Leukemia\u002FLymphoblastic Lymphoma (T-RRex)","Key Inclusion Criteria:\n\n* Disease Criteria: Evidence of T-ALL or T-LBL, as defined by World Health Organization (WHO) classification, and either relapse\u002Frefractory or MRD positive\n* Age: Lower age limit of ≥ 6 months; adequate organ function\n* Eastern Cooperative Oncology Group (ECOG)\u002FKarnofsky Performance Status 0 or 1\u002F70 and above at Screening.\n\nKey Exclusion Criteria:\n\n* Prior treatment with any anti-CD7 therapy.\n* Patients with decompensated hemolytic anemia.\n* Presence of Grade 2 to 4 acute or extensive chronic GvHD requiring systemic immunosuppression. Grade 1 GvHD not requiring immunosuppression or Grade 2 skin GvHD if treated with topical therapy only are acceptable.","ALL","1 Year",{"count":267,"type":268},125,"ESTIMATED","INTERVENTIONAL",[271],"PHASE2","The T-RRex study evaluates the efficacy of WU-CART-007 for patients with Relapsed\u002FRefractory (R\u002FR) T-Cell Acute Lymphoblastic Leukemia (T-ALL)\u002FLymphoblastic Lymphoma (LBL) and to WU-CART-007 as a therapy to induce complete Minimum Residual Disease (MRD) negative response",[274,275],"T-cell Acute Lymphoblastic Leukemia","Lymphoblastic Lymphoma",[277],"CAR-T Therapy","2026-05-09",{"date":280,"type":281},"2026-05-12","ACTUAL",{"date":283,"type":281},"2025-01-31",{"date":285,"type":268},"2028-12-30",{"name":5,"class":6},15]